Cheng-Ta Yang

25PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Aerodynamics (excl. hypersonic aerodynamics)Molecular targetsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Apr 29, 2026
Correction: Real-World Outcomes of Sequential Afatinib and Osimertinib Versus Afatinib and Chemotherapy in EGFR-Mutant NSCLC: Taiwan Multicenter GIANT Study.

|Aug 14, 2025
MCC950 Alleviates Fat Embolism-Induced Acute Respiratory Distress Syndrome Through Dual Modulation of NLRP3 Inflammasome and ERK Pathways.

Chin-Kuo Lin, Zheng-Wei Chen, Yu-Hao Lin

|Jul 29, 2025
Correction: Hung et al. Cul4A Modulates Invasion and Metastasis of Lung Cancer through Regulation of ANXA10. <i>Cancers</i> 2019, <i>11</i>, 618.

Ming-Szu Hung, Yi-Chuan Chen, Paul-Yann Lin

|Aug 22, 2024
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i>-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.

James Chih-Hsin Yang, Dae Ho Lee, Jong-Seok Lee

|May 25, 2024
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.

Ping-Chih Hsu, Bing-Chen Wu, Chin-Chou Wang

|May 16, 2024
Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer.

Gee-Chen Chang, Jin-Yuan Shih, Chong-Jen Yu

Pageof 5

Frequent Collaborators

8 joint publications

Ping-Chih Hsu

5 joint publications

Li-Chung Chiu

4 joint publications

Scott Chih-Hsi Kuo

3 joint publications

Ching-Fu Chang